nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—PTGS2—urinary bladder cancer	0.362	1	CbGaD
Tetrahydrobiopterin—NOS3—Doxorubicin—urinary bladder cancer	0.287	0.732	CbGbCtD
Tetrahydrobiopterin—PTGS2—Cisplatin—urinary bladder cancer	0.0531	0.135	CbGbCtD
Tetrahydrobiopterin—PTGS2—Etoposide—urinary bladder cancer	0.0522	0.133	CbGbCtD
Tetrahydrobiopterin—NOS3—penis—urinary bladder cancer	0.0161	0.239	CbGeAlD
Tetrahydrobiopterin—NOS3—umbilical vein—urinary bladder cancer	0.0133	0.197	CbGeAlD
Tetrahydrobiopterin—PAH—renal system—urinary bladder cancer	0.0048	0.0714	CbGeAlD
Tetrahydrobiopterin—TH—prostate gland—urinary bladder cancer	0.00427	0.0635	CbGeAlD
Tetrahydrobiopterin—NOS3—prostate gland—urinary bladder cancer	0.00384	0.0572	CbGeAlD
Tetrahydrobiopterin—TH—renal system—urinary bladder cancer	0.00291	0.0433	CbGeAlD
Tetrahydrobiopterin—NOS3—epithelium—urinary bladder cancer	0.00282	0.042	CbGeAlD
Tetrahydrobiopterin—NOS3—smooth muscle tissue—urinary bladder cancer	0.00272	0.0405	CbGeAlD
Tetrahydrobiopterin—NOS3—renal system—urinary bladder cancer	0.00262	0.039	CbGeAlD
Tetrahydrobiopterin—NOS3—female reproductive system—urinary bladder cancer	0.0021	0.0312	CbGeAlD
Tetrahydrobiopterin—NOS3—vagina—urinary bladder cancer	0.0019	0.0282	CbGeAlD
Tetrahydrobiopterin—TH—lymph node—urinary bladder cancer	0.00136	0.0203	CbGeAlD
Tetrahydrobiopterin—NOS3—lymph node—urinary bladder cancer	0.00123	0.0182	CbGeAlD
Tetrahydrobiopterin—PTGS2—prostate gland—urinary bladder cancer	0.00122	0.0181	CbGeAlD
Tetrahydrobiopterin—PTGS2—seminal vesicle—urinary bladder cancer	0.00103	0.0153	CbGeAlD
Tetrahydrobiopterin—PTGS2—epithelium—urinary bladder cancer	0.000894	0.0133	CbGeAlD
Tetrahydrobiopterin—PTGS2—smooth muscle tissue—urinary bladder cancer	0.000862	0.0128	CbGeAlD
Tetrahydrobiopterin—PTGS2—renal system—urinary bladder cancer	0.000829	0.0123	CbGeAlD
Tetrahydrobiopterin—PTGS2—urethra—urinary bladder cancer	0.000815	0.0121	CbGeAlD
Tetrahydrobiopterin—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.000762	0.0108	CcSEcCtD
Tetrahydrobiopterin—Cardiovascular disorder—Etoposide—urinary bladder cancer	0.00074	0.0105	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Valrubicin—urinary bladder cancer	0.000737	0.0105	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Valrubicin—urinary bladder cancer	0.000737	0.0105	CcSEcCtD
Tetrahydrobiopterin—Cough—Mitomycin—urinary bladder cancer	0.000687	0.00976	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Carboplatin—urinary bladder cancer	0.000683	0.0097	CcSEcCtD
Tetrahydrobiopterin—PTGS2—female reproductive system—urinary bladder cancer	0.000664	0.00989	CbGeAlD
Tetrahydrobiopterin—Diarrhoea—Valrubicin—urinary bladder cancer	0.000638	0.00907	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Valrubicin—urinary bladder cancer	0.000616	0.00876	CcSEcCtD
Tetrahydrobiopterin—PTGS2—vagina—urinary bladder cancer	0.000601	0.00894	CbGeAlD
Tetrahydrobiopterin—Vomiting—Valrubicin—urinary bladder cancer	0.000593	0.00843	CcSEcCtD
Tetrahydrobiopterin—Rash—Valrubicin—urinary bladder cancer	0.000588	0.00836	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Valrubicin—urinary bladder cancer	0.000587	0.00835	CcSEcCtD
Tetrahydrobiopterin—Polyuria—Cisplatin—urinary bladder cancer	0.000587	0.00834	CcSEcCtD
Tetrahydrobiopterin—Headache—Valrubicin—urinary bladder cancer	0.000584	0.0083	CcSEcCtD
Tetrahydrobiopterin—Nasal congestion—Cisplatin—urinary bladder cancer	0.000566	0.00804	CcSEcCtD
Tetrahydrobiopterin—Nausea—Valrubicin—urinary bladder cancer	0.000554	0.00787	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Fluorouracil—urinary bladder cancer	0.000544	0.00773	CcSEcCtD
Tetrahydrobiopterin—Irritability—Fluorouracil—urinary bladder cancer	0.000519	0.00738	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Cisplatin—urinary bladder cancer	0.000515	0.00733	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Mitomycin—urinary bladder cancer	0.000508	0.00722	CcSEcCtD
Tetrahydrobiopterin—Infestation—Thiotepa—urinary bladder cancer	0.000506	0.0072	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Thiotepa—urinary bladder cancer	0.000506	0.0072	CcSEcCtD
Tetrahydrobiopterin—Irritability—Cisplatin—urinary bladder cancer	0.000492	0.00699	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Fluorouracil—urinary bladder cancer	0.000486	0.00691	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Cisplatin—urinary bladder cancer	0.000461	0.00655	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Gemcitabine—urinary bladder cancer	0.000447	0.00635	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Mitomycin—urinary bladder cancer	0.000439	0.00625	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Fluorouracil—urinary bladder cancer	0.000437	0.00621	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Mitomycin—urinary bladder cancer	0.000425	0.00604	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Gemcitabine—urinary bladder cancer	0.00042	0.00597	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Fluorouracil—urinary bladder cancer	0.000419	0.00595	CcSEcCtD
Tetrahydrobiopterin—Infestation—Fluorouracil—urinary bladder cancer	0.000419	0.00595	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Gemcitabine—urinary bladder cancer	0.000418	0.00594	CcSEcCtD
Tetrahydrobiopterin—Cardiovascular disorder—Epirubicin—urinary bladder cancer	0.000415	0.0059	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Fluorouracil—urinary bladder cancer	0.000413	0.00587	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Fluorouracil—urinary bladder cancer	0.000411	0.00584	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Thiotepa—urinary bladder cancer	0.00041	0.00583	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Mitomycin—urinary bladder cancer	0.000408	0.00581	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Fluorouracil—urinary bladder cancer	0.000407	0.00579	CcSEcCtD
Tetrahydrobiopterin—Rash—Mitomycin—urinary bladder cancer	0.000405	0.00576	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Mitomycin—urinary bladder cancer	0.000405	0.00575	CcSEcCtD
Tetrahydrobiopterin—Headache—Mitomycin—urinary bladder cancer	0.000402	0.00572	CcSEcCtD
Tetrahydrobiopterin—Respiratory failure—Methotrexate—urinary bladder cancer	0.000397	0.00564	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Thiotepa—urinary bladder cancer	0.000396	0.00563	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Cisplatin—urinary bladder cancer	0.000391	0.00557	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Cisplatin—urinary bladder cancer	0.000389	0.00553	CcSEcCtD
Tetrahydrobiopterin—PTGS2—lymph node—urinary bladder cancer	0.000389	0.00578	CbGeAlD
Tetrahydrobiopterin—Cardiovascular disorder—Doxorubicin—urinary bladder cancer	0.000384	0.00546	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Etoposide—urinary bladder cancer	0.000382	0.00542	CcSEcCtD
Tetrahydrobiopterin—Nausea—Mitomycin—urinary bladder cancer	0.000381	0.00542	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Gemcitabine—urinary bladder cancer	0.00038	0.0054	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Gemcitabine—urinary bladder cancer	0.000377	0.00536	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Fluorouracil—urinary bladder cancer	0.000373	0.00531	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Etoposide—urinary bladder cancer	0.000364	0.00517	CcSEcCtD
Tetrahydrobiopterin—Infestation—Etoposide—urinary bladder cancer	0.000364	0.00517	CcSEcCtD
Tetrahydrobiopterin—Agitation—Thiotepa—urinary bladder cancer	0.000364	0.00517	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Etoposide—urinary bladder cancer	0.000359	0.0051	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Etoposide—urinary bladder cancer	0.000357	0.00507	CcSEcCtD
Tetrahydrobiopterin—Urine output increased—Methotrexate—urinary bladder cancer	0.000352	0.00501	CcSEcCtD
Tetrahydrobiopterin—Cough—Thiotepa—urinary bladder cancer	0.000345	0.00491	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Gemcitabine—urinary bladder cancer	0.000345	0.0049	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Thiotepa—urinary bladder cancer	0.000343	0.00487	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Thiotepa—urinary bladder cancer	0.000337	0.00479	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.000335	0.00476	CcSEcCtD
Tetrahydrobiopterin—Polyuria—Methotrexate—urinary bladder cancer	0.000322	0.00458	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Cisplatin—urinary bladder cancer	0.000321	0.00457	CcSEcCtD
Tetrahydrobiopterin—Infection—Thiotepa—urinary bladder cancer	0.000321	0.00456	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Thiotepa—urinary bladder cancer	0.000317	0.0045	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Thiotepa—urinary bladder cancer	0.000314	0.00446	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Cisplatin—urinary bladder cancer	0.00031	0.00441	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Etoposide—urinary bladder cancer	0.000294	0.00418	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.000294	0.00418	CcSEcCtD
Tetrahydrobiopterin—Cough—Gemcitabine—urinary bladder cancer	0.000291	0.00413	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Thiotepa—urinary bladder cancer	0.000284	0.00404	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Fluorouracil—urinary bladder cancer	0.000284	0.00403	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Gemcitabine—urinary bladder cancer	0.000283	0.00403	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.000281	0.004	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000279	0.00396	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000272	0.00386	CcSEcCtD
Tetrahydrobiopterin—Infection—Gemcitabine—urinary bladder cancer	0.00027	0.00384	CcSEcCtD
Tetrahydrobiopterin—Irritability—Methotrexate—urinary bladder cancer	0.00027	0.00384	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Cisplatin—urinary bladder cancer	0.000269	0.00382	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000267	0.0038	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000266	0.00379	CcSEcCtD
Tetrahydrobiopterin—Infection—Fluorouracil—urinary bladder cancer	0.000265	0.00377	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Epirubicin—urinary bladder cancer	0.000265	0.00376	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000264	0.00375	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Gemcitabine—urinary bladder cancer	0.000264	0.00375	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000262	0.00373	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000262	0.00372	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Thiotepa—urinary bladder cancer	0.000255	0.00363	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Thiotepa—urinary bladder cancer	0.000255	0.00363	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000253	0.0036	CcSEcCtD
Tetrahydrobiopterin—Infection—Cisplatin—urinary bladder cancer	0.000252	0.00358	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000248	0.00353	CcSEcCtD
Tetrahydrobiopterin—Cough—Etoposide—urinary bladder cancer	0.000248	0.00353	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000248	0.00352	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Etoposide—urinary bladder cancer	0.000246	0.0035	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Cisplatin—urinary bladder cancer	0.000246	0.0035	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.000245	0.00348	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000243	0.00346	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.000242	0.00344	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00024	0.00342	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000238	0.00338	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.000237	0.00336	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000235	0.00334	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000235	0.00333	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Epirubicin—urinary bladder cancer	0.000234	0.00333	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000232	0.0033	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000231	0.00328	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000231	0.00328	CcSEcCtD
Tetrahydrobiopterin—Infection—Etoposide—urinary bladder cancer	0.00023	0.00328	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Methotrexate—urinary bladder cancer	0.000229	0.00325	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.000227	0.00323	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Etoposide—urinary bladder cancer	0.000225	0.0032	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000224	0.00318	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Thiotepa—urinary bladder cancer	0.000221	0.00314	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.000219	0.00311	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000219	0.00311	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Methotrexate—urinary bladder cancer	0.000218	0.0031	CcSEcCtD
Tetrahydrobiopterin—Infestation—Methotrexate—urinary bladder cancer	0.000218	0.0031	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Doxorubicin—urinary bladder cancer	0.000217	0.00308	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000215	0.00305	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Epirubicin—urinary bladder cancer	0.000214	0.00304	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Thiotepa—urinary bladder cancer	0.000214	0.00304	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.000213	0.00302	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000211	0.003	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Thiotepa—urinary bladder cancer	0.000205	0.00292	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Epirubicin—urinary bladder cancer	0.000204	0.0029	CcSEcCtD
Tetrahydrobiopterin—Infestation—Epirubicin—urinary bladder cancer	0.000204	0.0029	CcSEcCtD
Tetrahydrobiopterin—Rash—Thiotepa—urinary bladder cancer	0.000204	0.0029	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Thiotepa—urinary bladder cancer	0.000203	0.00289	CcSEcCtD
Tetrahydrobiopterin—Headache—Thiotepa—urinary bladder cancer	0.000202	0.00288	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.0002	0.00285	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Cisplatin—urinary bladder cancer	0.0002	0.00285	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000198	0.00282	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Doxorubicin—urinary bladder cancer	0.000198	0.00281	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000197	0.0028	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000197	0.0028	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Methotrexate—urinary bladder cancer	0.000194	0.00276	CcSEcCtD
Tetrahydrobiopterin—Nausea—Thiotepa—urinary bladder cancer	0.000192	0.00273	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00019	0.0027	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000189	0.00268	CcSEcCtD
Tetrahydrobiopterin—Infestation—Doxorubicin—urinary bladder cancer	0.000189	0.00268	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000187	0.00265	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000186	0.00264	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Etoposide—urinary bladder cancer	0.000183	0.00261	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Etoposide—urinary bladder cancer	0.000183	0.00261	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000183	0.00261	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000183	0.0026	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Epirubicin—urinary bladder cancer	0.000182	0.00258	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Epirubicin—urinary bladder cancer	0.00018	0.00256	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Fluorouracil—urinary bladder cancer	0.000177	0.00251	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000176	0.00251	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000173	0.00246	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Gemcitabine—urinary bladder cancer	0.000173	0.00246	CcSEcCtD
Tetrahydrobiopterin—Rash—Gemcitabine—urinary bladder cancer	0.000171	0.00244	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000171	0.00243	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000171	0.00243	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Methotrexate—urinary bladder cancer	0.00017	0.00242	CcSEcCtD
Tetrahydrobiopterin—Headache—Gemcitabine—urinary bladder cancer	0.00017	0.00242	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Fluorouracil—urinary bladder cancer	0.00017	0.00241	CcSEcCtD
Tetrahydrobiopterin—Rash—Fluorouracil—urinary bladder cancer	0.000168	0.00239	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000168	0.00239	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000168	0.00239	CcSEcCtD
Tetrahydrobiopterin—Headache—Fluorouracil—urinary bladder cancer	0.000167	0.00238	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000167	0.00237	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000165	0.00235	CcSEcCtD
Tetrahydrobiopterin—Nausea—Gemcitabine—urinary bladder cancer	0.000161	0.00229	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Cisplatin—urinary bladder cancer	0.000161	0.00229	CcSEcCtD
Tetrahydrobiopterin—Rash—Cisplatin—urinary bladder cancer	0.00016	0.00227	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Cisplatin—urinary bladder cancer	0.00016	0.00227	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Epirubicin—urinary bladder cancer	0.000159	0.00227	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Etoposide—urinary bladder cancer	0.000159	0.00226	CcSEcCtD
Tetrahydrobiopterin—Nausea—Fluorouracil—urinary bladder cancer	0.000159	0.00226	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Etoposide—urinary bladder cancer	0.000153	0.00218	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000153	0.00217	CcSEcCtD
Tetrahydrobiopterin—Nausea—Cisplatin—urinary bladder cancer	0.00015	0.00214	CcSEcCtD
Tetrahydrobiopterin—Cough—Methotrexate—urinary bladder cancer	0.000149	0.00211	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Methotrexate—urinary bladder cancer	0.000148	0.0021	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Etoposide—urinary bladder cancer	0.000148	0.0021	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Doxorubicin—urinary bladder cancer	0.000147	0.0021	CcSEcCtD
Tetrahydrobiopterin—Agitation—Epirubicin—urinary bladder cancer	0.000146	0.00208	CcSEcCtD
Tetrahydrobiopterin—Rash—Etoposide—urinary bladder cancer	0.000146	0.00208	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Etoposide—urinary bladder cancer	0.000146	0.00208	CcSEcCtD
Tetrahydrobiopterin—Headache—Etoposide—urinary bladder cancer	0.000145	0.00207	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Methotrexate—urinary bladder cancer	0.000145	0.00206	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000144	0.00205	CcSEcCtD
Tetrahydrobiopterin—Cough—Epirubicin—urinary bladder cancer	0.000139	0.00198	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000139	0.00198	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Epirubicin—urinary bladder cancer	0.000138	0.00196	CcSEcCtD
Tetrahydrobiopterin—Infection—Methotrexate—urinary bladder cancer	0.000138	0.00196	CcSEcCtD
Tetrahydrobiopterin—Nausea—Etoposide—urinary bladder cancer	0.000138	0.00196	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000136	0.00194	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Epirubicin—urinary bladder cancer	0.000136	0.00193	CcSEcCtD
Tetrahydrobiopterin—Agitation—Doxorubicin—urinary bladder cancer	0.000135	0.00193	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Methotrexate—urinary bladder cancer	0.000135	0.00192	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000135	0.00192	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00013	0.00185	CcSEcCtD
Tetrahydrobiopterin—Infection—Epirubicin—urinary bladder cancer	0.000129	0.00184	CcSEcCtD
Tetrahydrobiopterin—Cough—Doxorubicin—urinary bladder cancer	0.000129	0.00183	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Doxorubicin—urinary bladder cancer	0.000128	0.00182	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000128	0.00181	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000127	0.0018	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Epirubicin—urinary bladder cancer	0.000126	0.0018	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Doxorubicin—urinary bladder cancer	0.000126	0.00178	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000125	0.00177	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000122	0.00174	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00012	0.00171	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00012	0.00171	CcSEcCtD
Tetrahydrobiopterin—Infection—Doxorubicin—urinary bladder cancer	0.00012	0.0017	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000118	0.00168	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000118	0.00168	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Doxorubicin—urinary bladder cancer	0.000117	0.00166	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000114	0.00163	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000114	0.00162	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000112	0.0016	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Methotrexate—urinary bladder cancer	0.00011	0.00156	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Methotrexate—urinary bladder cancer	0.00011	0.00156	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00011	0.00156	CcSEcCtD
Tetrahydrobiopterin—NOS3—Hemostasis—IFNA2—urinary bladder cancer	0.000107	0.000992	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000106	0.00151	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—GSTT1—urinary bladder cancer	0.000106	0.000986	CbGpPWpGaD
Tetrahydrobiopterin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000106	0.00151	CcSEcCtD
Tetrahydrobiopterin—NOS3—Metabolism—SLC19A1—urinary bladder cancer	0.000106	0.000982	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—urinary bladder cancer	0.000106	0.00098	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000105	0.000974	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000104	0.00148	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000103	0.000959	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PRSS3—urinary bladder cancer	0.000103	0.000957	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—SRC—urinary bladder cancer	0.000103	0.000956	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000103	0.000955	CbGpPWpGaD
Tetrahydrobiopterin—Body temperature increased—Epirubicin—urinary bladder cancer	0.000103	0.00146	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000103	0.00146	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000102	0.00146	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000101	0.000938	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—HRAS—urinary bladder cancer	0.000101	0.000938	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—GSTP1—urinary bladder cancer	0.000101	0.000934	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	9.84e-05	0.0014	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	9.63e-05	0.000894	CbGpPWpGaD
Tetrahydrobiopterin—Hypersensitivity—Epirubicin—urinary bladder cancer	9.58e-05	0.00136	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	9.55e-05	0.000886	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—HRAS—urinary bladder cancer	9.54e-05	0.000885	CbGpPWpGaD
Tetrahydrobiopterin—Body temperature increased—Doxorubicin—urinary bladder cancer	9.51e-05	0.00135	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Doxorubicin—urinary bladder cancer	9.51e-05	0.00135	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Methotrexate—urinary bladder cancer	9.51e-05	0.00135	CcSEcCtD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—CDKN2A—urinary bladder cancer	9.42e-05	0.000874	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—CDK4—urinary bladder cancer	9.4e-05	0.000872	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—TYMS—urinary bladder cancer	9.36e-05	0.000869	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—LIG1—urinary bladder cancer	9.34e-05	0.000866	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—RRM2—urinary bladder cancer	9.29e-05	0.000862	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—NCOR1—urinary bladder cancer	9.25e-05	0.000859	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—GSTM1—urinary bladder cancer	9.25e-05	0.000859	CbGpPWpGaD
Tetrahydrobiopterin—TH—Circadian rythm related genes—TP53—urinary bladder cancer	9.21e-05	0.000854	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Methotrexate—urinary bladder cancer	9.19e-05	0.00131	CcSEcCtD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—EGFR—urinary bladder cancer	9.03e-05	0.000838	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—urinary bladder cancer	9.01e-05	0.000836	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Epirubicin—urinary bladder cancer	8.9e-05	0.00127	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Doxorubicin—urinary bladder cancer	8.87e-05	0.00126	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—GPX1—urinary bladder cancer	8.86e-05	0.000822	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Methotrexate—urinary bladder cancer	8.84e-05	0.00126	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—NQO1—urinary bladder cancer	8.83e-05	0.000819	CbGpPWpGaD
Tetrahydrobiopterin—Rash—Methotrexate—urinary bladder cancer	8.76e-05	0.00125	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Methotrexate—urinary bladder cancer	8.75e-05	0.00124	CcSEcCtD
Tetrahydrobiopterin—Headache—Methotrexate—urinary bladder cancer	8.71e-05	0.00124	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—ERCC2—urinary bladder cancer	8.7e-05	0.000807	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—ENO2—urinary bladder cancer	8.6e-05	0.000798	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—HPGDS—urinary bladder cancer	8.6e-05	0.000798	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Epirubicin—urinary bladder cancer	8.6e-05	0.00122	CcSEcCtD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—KRAS—urinary bladder cancer	8.53e-05	0.000792	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	8.35e-05	0.000774	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—GSTT1—urinary bladder cancer	8.35e-05	0.000774	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Epirubicin—urinary bladder cancer	8.27e-05	0.00118	CcSEcCtD
Tetrahydrobiopterin—Nausea—Methotrexate—urinary bladder cancer	8.25e-05	0.00117	CcSEcCtD
Tetrahydrobiopterin—NOS3—Metabolism—TYMP—urinary bladder cancer	8.25e-05	0.000765	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Doxorubicin—urinary bladder cancer	8.23e-05	0.00117	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HDAC4—urinary bladder cancer	8.23e-05	0.000764	CbGpPWpGaD
Tetrahydrobiopterin—Rash—Epirubicin—urinary bladder cancer	8.2e-05	0.00117	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	8.2e-05	0.000761	CbGpPWpGaD
Tetrahydrobiopterin—Dermatitis—Epirubicin—urinary bladder cancer	8.19e-05	0.00116	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—MTHFR—urinary bladder cancer	8.18e-05	0.000759	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—RB1—urinary bladder cancer	8.17e-05	0.000758	CbGpPWpGaD
Tetrahydrobiopterin—Headache—Epirubicin—urinary bladder cancer	8.15e-05	0.00116	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	8.12e-05	0.000753	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—NCOR1—urinary bladder cancer	8.08e-05	0.00075	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—CCND1—urinary bladder cancer	7.96e-05	0.000739	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Doxorubicin—urinary bladder cancer	7.96e-05	0.00113	CcSEcCtD
Tetrahydrobiopterin—Nausea—Epirubicin—urinary bladder cancer	7.72e-05	0.0011	CcSEcCtD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	7.7e-05	0.000715	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Doxorubicin—urinary bladder cancer	7.65e-05	0.00109	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—ERCC2—urinary bladder cancer	7.6e-05	0.000705	CbGpPWpGaD
Tetrahydrobiopterin—Rash—Doxorubicin—urinary bladder cancer	7.59e-05	0.00108	CcSEcCtD
Tetrahydrobiopterin—NOS3—Hemostasis—PLAU—urinary bladder cancer	7.58e-05	0.000704	CbGpPWpGaD
Tetrahydrobiopterin—Dermatitis—Doxorubicin—urinary bladder cancer	7.58e-05	0.00108	CcSEcCtD
Tetrahydrobiopterin—Headache—Doxorubicin—urinary bladder cancer	7.54e-05	0.00107	CcSEcCtD
Tetrahydrobiopterin—NOS3—Metabolism—NAT2—urinary bladder cancer	7.46e-05	0.000692	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—RHOA—urinary bladder cancer	7.42e-05	0.000688	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—GSTP1—urinary bladder cancer	7.36e-05	0.000683	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—EP300—urinary bladder cancer	7.33e-05	0.00068	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	7.26e-05	0.000674	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—HRAS—urinary bladder cancer	7.25e-05	0.000673	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Doxorubicin—urinary bladder cancer	7.15e-05	0.00102	CcSEcCtD
Tetrahydrobiopterin—PAH—Disease—MTHFR—urinary bladder cancer	7.14e-05	0.000663	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—ENO2—urinary bladder cancer	7.12e-05	0.000661	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—TERT—urinary bladder cancer	7.12e-05	0.000661	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—NQO1—urinary bladder cancer	6.94e-05	0.000643	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—GLI1—urinary bladder cancer	6.9e-05	0.00064	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—TYMS—urinary bladder cancer	6.85e-05	0.000635	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—NCOR1—urinary bladder cancer	6.77e-05	0.000628	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—GSTM1—urinary bladder cancer	6.77e-05	0.000628	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—RBX1—urinary bladder cancer	6.75e-05	0.000626	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—GSTO2—urinary bladder cancer	6.65e-05	0.000617	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PPARG—urinary bladder cancer	6.63e-05	0.000615	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—FGFR3—urinary bladder cancer	6.53e-05	0.000606	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—CXCL8—urinary bladder cancer	6.51e-05	0.000604	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—GPX1—urinary bladder cancer	6.48e-05	0.000601	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—RRM2—urinary bladder cancer	6.44e-05	0.000597	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	6.42e-05	0.000596	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	6.39e-05	0.000593	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—MYC—urinary bladder cancer	6.39e-05	0.000593	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—CREBBP—urinary bladder cancer	6.37e-05	0.000591	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	6.36e-05	0.000591	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—ERCC2—urinary bladder cancer	6.36e-05	0.00059	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—CREBBP—urinary bladder cancer	6.26e-05	0.00058	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—IL2—urinary bladder cancer	6.22e-05	0.000577	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—IGF1—urinary bladder cancer	6.18e-05	0.000573	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—CCND1—urinary bladder cancer	6.07e-05	0.000563	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—JAG1—urinary bladder cancer	6.04e-05	0.000561	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—MTHFR—urinary bladder cancer	5.98e-05	0.000555	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—HPGDS—urinary bladder cancer	5.96e-05	0.000553	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ENO2—urinary bladder cancer	5.96e-05	0.000553	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—KRAS—urinary bladder cancer	5.9e-05	0.000548	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—MMP9—urinary bladder cancer	5.89e-05	0.000547	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTZ1—urinary bladder cancer	5.87e-05	0.000545	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—GSTT1—urinary bladder cancer	5.78e-05	0.000537	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—GSTP1—urinary bladder cancer	5.78e-05	0.000537	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—TNF—urinary bladder cancer	5.73e-05	0.000532	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—RHOA—urinary bladder cancer	5.66e-05	0.000525	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	5.58e-05	0.000518	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTO2—urinary bladder cancer	5.57e-05	0.000517	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NAT1—urinary bladder cancer	5.57e-05	0.000517	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—CREBBP—urinary bladder cancer	5.56e-05	0.000516	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	5.51e-05	0.000511	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.48e-05	0.000508	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—TYMS—urinary bladder cancer	5.38e-05	0.000499	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—NCOR1—urinary bladder cancer	5.32e-05	0.000493	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—GSTM1—urinary bladder cancer	5.32e-05	0.000493	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PTGS2—urinary bladder cancer	5.22e-05	0.000484	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SLC19A1—urinary bladder cancer	5.17e-05	0.00048	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—UGT2B7—urinary bladder cancer	5.09e-05	0.000473	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—GPX1—urinary bladder cancer	5.09e-05	0.000472	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PRSS3—urinary bladder cancer	5.04e-05	0.000468	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—RHOA—urinary bladder cancer	5.03e-05	0.000467	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—HRAS—urinary bladder cancer	5.02e-05	0.000465	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—ERCC2—urinary bladder cancer	5e-05	0.000464	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—MYC—urinary bladder cancer	4.87e-05	0.000452	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PPARG—urinary bladder cancer	4.85e-05	0.00045	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—NQO1—urinary bladder cancer	4.81e-05	0.000446	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HDAC4—urinary bladder cancer	4.81e-05	0.000446	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—EGFR—urinary bladder cancer	4.76e-05	0.000442	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—IL2—urinary bladder cancer	4.75e-05	0.000441	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—RBX1—urinary bladder cancer	4.73e-05	0.000439	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—MTHFR—urinary bladder cancer	4.7e-05	0.000436	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	4.67e-05	0.000433	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—CREBBP—urinary bladder cancer	4.66e-05	0.000432	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—ERBB2—urinary bladder cancer	4.66e-05	0.000432	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP4B1—urinary bladder cancer	4.59e-05	0.000425	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PTGS2—urinary bladder cancer	4.56e-05	0.000423	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PTEN—urinary bladder cancer	4.55e-05	0.000422	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—TNF—urinary bladder cancer	4.53e-05	0.000421	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TSC1—urinary bladder cancer	4.44e-05	0.000412	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—NCOR1—urinary bladder cancer	4.4e-05	0.000408	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—EP300—urinary bladder cancer	4.34e-05	0.000403	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC19A1—urinary bladder cancer	4.33e-05	0.000402	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—EP300—urinary bladder cancer	4.26e-05	0.000395	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—JAG1—urinary bladder cancer	4.23e-05	0.000393	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PRSS3—urinary bladder cancer	4.22e-05	0.000392	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—SRC—urinary bladder cancer	4.14e-05	0.000384	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—ERCC2—urinary bladder cancer	4.14e-05	0.000384	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	4.13e-05	0.000383	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—GSTP1—urinary bladder cancer	4.01e-05	0.000372	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—TP53—urinary bladder cancer	4e-05	0.000371	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.99e-05	0.00037	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.98e-05	0.00037	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—CDKN1A—urinary bladder cancer	3.98e-05	0.000369	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PTEN—urinary bladder cancer	3.97e-05	0.000369	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MTHFR—urinary bladder cancer	3.89e-05	0.000361	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—TERT—urinary bladder cancer	3.88e-05	0.00036	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—LIG1—urinary bladder cancer	3.82e-05	0.000354	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PTGS2—urinary bladder cancer	3.81e-05	0.000354	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PPARG—urinary bladder cancer	3.81e-05	0.000353	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.8e-05	0.000352	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—EP300—urinary bladder cancer	3.79e-05	0.000352	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—TYMS—urinary bladder cancer	3.73e-05	0.000346	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.69e-05	0.000343	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—NCOR1—urinary bladder cancer	3.68e-05	0.000342	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—GSTM1—urinary bladder cancer	3.68e-05	0.000342	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—SRC—urinary bladder cancer	3.68e-05	0.000342	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—CREBBP—urinary bladder cancer	3.66e-05	0.00034	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—FGFR3—urinary bladder cancer	3.56e-05	0.00033	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—GPX1—urinary bladder cancer	3.53e-05	0.000327	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ERCC2—urinary bladder cancer	3.46e-05	0.000321	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—KRAS—urinary bladder cancer	3.43e-05	0.000318	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—S100B—urinary bladder cancer	3.43e-05	0.000318	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.38e-05	0.000314	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—TYMP—urinary bladder cancer	3.37e-05	0.000313	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PTEN—urinary bladder cancer	3.33e-05	0.000309	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.31e-05	0.000307	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—MYC—urinary bladder cancer	3.3e-05	0.000306	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—MTHFR—urinary bladder cancer	3.26e-05	0.000302	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.24e-05	0.000301	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.24e-05	0.0003	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—EGFR—urinary bladder cancer	3.23e-05	0.0003	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—EP300—urinary bladder cancer	3.17e-05	0.000294	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.08e-05	0.000286	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—NCOR1—urinary bladder cancer	3.08e-05	0.000286	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.06e-05	0.000284	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NAT2—urinary bladder cancer	3.05e-05	0.000283	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—KRAS—urinary bladder cancer	3.05e-05	0.000283	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—TP53—urinary bladder cancer	3.05e-05	0.000283	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CREBBP—urinary bladder cancer	3.03e-05	0.000281	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTGS2—urinary bladder cancer	3e-05	0.000278	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—HRAS—urinary bladder cancer	2.92e-05	0.000271	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ENO2—urinary bladder cancer	2.91e-05	0.00027	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—RBX1—urinary bladder cancer	2.76e-05	0.000256	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—RHOA—urinary bladder cancer	2.74e-05	0.000254	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.72e-05	0.000252	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TERT—urinary bladder cancer	2.72e-05	0.000252	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PPARG—urinary bladder cancer	2.64e-05	0.000245	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—RRM2—urinary bladder cancer	2.63e-05	0.000244	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTEN—urinary bladder cancer	2.61e-05	0.000242	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—HRAS—urinary bladder cancer	2.59e-05	0.000241	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CREBBP—urinary bladder cancer	2.54e-05	0.000235	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—ERBB2—urinary bladder cancer	2.54e-05	0.000235	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—EP300—urinary bladder cancer	2.49e-05	0.000231	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FGFR3—urinary bladder cancer	2.49e-05	0.000231	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTGS2—urinary bladder cancer	2.48e-05	0.00023	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—JAG1—urinary bladder cancer	2.47e-05	0.000229	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HPGDS—urinary bladder cancer	2.44e-05	0.000226	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ENO2—urinary bladder cancer	2.44e-05	0.000226	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.42e-05	0.000225	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ESR1—urinary bladder cancer	2.42e-05	0.000225	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTT1—urinary bladder cancer	2.37e-05	0.000219	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.33e-05	0.000216	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CDKN1A—urinary bladder cancer	2.17e-05	0.000201	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTEN—urinary bladder cancer	2.16e-05	0.000201	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CREBBP—urinary bladder cancer	2.12e-05	0.000197	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IGF1—urinary bladder cancer	2.09e-05	0.000194	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTGS2—urinary bladder cancer	2.08e-05	0.000193	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—EP300—urinary bladder cancer	2.06e-05	0.000191	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—SRC—urinary bladder cancer	2.01e-05	0.000186	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NQO1—urinary bladder cancer	1.97e-05	0.000182	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—RHOA—urinary bladder cancer	1.92e-05	0.000178	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTEN—urinary bladder cancer	1.81e-05	0.000168	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NCOR1—urinary bladder cancer	1.8e-05	0.000167	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MYC—urinary bladder cancer	1.8e-05	0.000167	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ERBB2—urinary bladder cancer	1.78e-05	0.000165	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—EGFR—urinary bladder cancer	1.76e-05	0.000163	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—EP300—urinary bladder cancer	1.73e-05	0.00016	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ERCC2—urinary bladder cancer	1.69e-05	0.000157	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CXCL8—urinary bladder cancer	1.68e-05	0.000156	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.66e-05	0.000154	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—KRAS—urinary bladder cancer	1.66e-05	0.000154	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTP1—urinary bladder cancer	1.64e-05	0.000152	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL2—urinary bladder cancer	1.61e-05	0.000149	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MTHFR—urinary bladder cancer	1.59e-05	0.000148	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.59e-05	0.000147	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TERT—urinary bladder cancer	1.59e-05	0.000147	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCND1—urinary bladder cancer	1.57e-05	0.000146	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—TYMS—urinary bladder cancer	1.52e-05	0.000141	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MMP9—urinary bladder cancer	1.52e-05	0.000141	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CDKN1A—urinary bladder cancer	1.52e-05	0.000141	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PTEN—urinary bladder cancer	1.51e-05	0.000141	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NCOR1—urinary bladder cancer	1.51e-05	0.00014	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTM1—urinary bladder cancer	1.51e-05	0.00014	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FGFR3—urinary bladder cancer	1.46e-05	0.000135	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EP300—urinary bladder cancer	1.44e-05	0.000134	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GPX1—urinary bladder cancer	1.44e-05	0.000134	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ERCC2—urinary bladder cancer	1.42e-05	0.000131	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—HRAS—urinary bladder cancer	1.41e-05	0.000131	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SRC—urinary bladder cancer	1.4e-05	0.00013	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—MTHFR—urinary bladder cancer	1.33e-05	0.000124	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MYC—urinary bladder cancer	1.26e-05	0.000117	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CREBBP—urinary bladder cancer	1.24e-05	0.000115	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EGFR—urinary bladder cancer	1.23e-05	0.000114	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KRAS—urinary bladder cancer	1.16e-05	0.000108	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—RHOA—urinary bladder cancer	1.12e-05	0.000104	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PPARG—urinary bladder cancer	1.08e-05	0.0001	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CREBBP—urinary bladder cancer	1.04e-05	9.62e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ERBB2—urinary bladder cancer	1.04e-05	9.62e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TP53—urinary bladder cancer	1.03e-05	9.59e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HRAS—urinary bladder cancer	9.89e-06	9.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CDKN1A—urinary bladder cancer	8.87e-06	8.23e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PTEN—urinary bladder cancer	8.85e-06	8.21e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—EP300—urinary bladder cancer	8.44e-06	7.83e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SRC—urinary bladder cancer	8.2e-06	7.61e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PTEN—urinary bladder cancer	7.41e-06	6.87e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MYC—urinary bladder cancer	7.35e-06	6.82e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—EGFR—urinary bladder cancer	7.19e-06	6.67e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—EP300—urinary bladder cancer	7.06e-06	6.56e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—KRAS—urinary bladder cancer	6.79e-06	6.3e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HRAS—urinary bladder cancer	5.77e-06	5.36e-05	CbGpPWpGaD
